Hyperoside inhibits pancreatic lipase in vitro and reduces fat accumulation in vivo

Xinyue Zhang,Dan Li,Kexin Wang,Jiao Xie,Yaojie Liu,Tianxin Wang,Suwen Liu,Qun Huang,Qingbin Guo,Hao Wang
DOI: https://doi.org/10.1039/d2fo03219h
2023-04-17
Abstract:Hyperoside, the main component of many anti-obesity plants, might exhibit the lipase inhibition effect to reduce fat accumulation. The anti-obesity effect of hyperoside was investigated by studying its inhibitory effect and mechanism on pancreatic lipase in vitro and evaluating its ability to reduce lipid accumulation in vivo. Hyperoside was a mixed-type inhibitor of lipase with IC50 of 0.67 ± 0.02 mmol/L in vitro. Hyperoside changed the secondary structure of lipase, increased the content of α-helix, and changed the microenvironment of lipase through static quenching. The interaction between hyperoside and lipase results from a strong binding spontaneous exothermic reaction, mainly through hydrogen bonding, van der Waals force and electrostatic force. Hyperoside protected hepatic lipid accumulation and adipose tissue hypertrophy and reduced the expression of inflammatory factors in high-fat diet-induced rat. In addition, hyperoside had a good inhibitory effect on lipase activity in serum and increased fecal fat excretion, thereby reducing lipid absorption in vivo. The study provides theoretical information for research and development of hyperoside as a fat-reducing functional food in future.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?